Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Invested Capital (2021 - 2025)

Historic Invested Capital for Cardio Diagnostics Holdings (CDIO) over the last 5 years, with Q3 2025 value amounting to $8.2 million.

  • Cardio Diagnostics Holdings' Invested Capital rose 12113.84% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year increase of 12113.84%. This contributed to the annual value of $9.6 million for FY2024, which is 22310.3% up from last year.
  • Latest data reveals that Cardio Diagnostics Holdings reported Invested Capital of $8.2 million as of Q3 2025, which was up 12113.84% from $9.7 million recorded in Q2 2025.
  • Cardio Diagnostics Holdings' Invested Capital's 5-year high stood at $11.4 million during Q1 2025, with a 5-year trough of $24279.0 in Q3 2021.
  • Its 5-year average for Invested Capital is $5.2 million, with a median of $4.0 million in 2022.
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 4111235.64% in 2022, then tumbled by 6527.55% in 2023.
  • Cardio Diagnostics Holdings' Invested Capital (Quarter) stood at $1.1 million in 2021, then soared by 302.74% to $4.3 million in 2022, then plummeted by 31.23% to $3.0 million in 2023, then surged by 223.1% to $9.6 million in 2024, then decreased by 14.71% to $8.2 million in 2025.
  • Its Invested Capital was $8.2 million in Q3 2025, compared to $9.7 million in Q2 2025 and $11.4 million in Q1 2025.